Refine publication list

Chart

 to  

• English (95)
• German (6)

• Hehlmann, Rüdiger (45)
• Saußele, Susanne (36)
• Fabarius, Alice (24)
• Hofmann, Wolf-Karsten (24)
• Hanfstein, Benjamin (22)
• Hochhaus, Andreas (20)
• Proetel, Ulrike (17)

• Erben, Philipp (15)
• Dietz, Christian (13)
• Reiter, Andreas (10)
• Kalmanti, Lida (9)
• Dengler, Jolanta (9)
• Seifarth, Wolfgang (8)
• Kreil, Sebastian (7)
• Merx, Kirsten (7)
• Paschka, Peter (7)
• Berger, Ute (7)
• Ho, Anthony Dick (6)
• Weißer, Andreas (6)
• La Rosée, Paul (5)
• Prinzhorn, Wiltrud (4)
• Rinaldetti, Sébastien (4)
• Kleiner, Helga (4)
• Leitner, Armin (4)
• Metzgeroth, Georgia (3)
• Schwaab, Juliana (3)
• Schreiber, Annette (3)
• Emig, Michael (3)
• Jung-Munkwitz, Susanne (3)
• Buchheidt, Dieter (2)
• Spiess, Birgit (2)
• Lengfelder, Eva (2)
• Nolte, Florian (2)
• Mossner, Maximilian (2)
• Boch, Tobias (2)
• Egerer, Gerlinde (2)
• Stehle, Michael (2)
• Merker, Natalia (2)
• Ruppenthal, Sabrina (2)
• Frühauf, Stefan (2)
• (further entries exist...)

• Lahaye, T. (6)
• Hochhaus, Andreas (5)
• Gschaidmeier, Harald (5)
• Lauseker, Michael (4)
• White, Helen (4)
• Baccarani, Michele (1942-2021) (3)
• Cortés, Jorge Eduardo (3)

• Gratwohl, Alois (3)
• Cross, Nicholas C. P. (3)
• Schoch, C. (3)
• Schoch, Claudia (2)
• Nicolini, Franck E. (2)
• Lippert, Eric (2)
• Pfirrmann, Markus (2)
• Hossfeld, Dieter K. (2)
• Burchert, Andreas (2)
• Branford, Susan (2)
• Martinelli, Giovanni (2)
• Cortes, Jorge (2)
• Michallet, Mauricette (2)
• Colomer, Dolors (2)
• Hänel, Mathias (2)
• Schlegelberger, Brigitte (2)
• Fischer, Thomas (2)
• Balleisen, Leopold (2)
• Soverini, Simona (2)
• Roche-Lestienne, Catherine (2)
• Peter, Senaka (2)
• Morisset, Stéphane (2)
• Mauro, Michael J. (2)
• Goldman, John M. (2)
• Branford, Susan (2)
• Homburg, C. (1)
• Petzold, A. (1)
• Ernst, Thomas (1)
• Dengler, Robert (1)
• Barreto Miranda, Manuel (1)
• Dreyling, Martin (1)
• Philipp, Martin Bernd (1)
• Bolton-Gillespie, Elisabeth (1)
• (further entries exist...)

Publications in heiBIB     

• White, Helen: Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study : chronic myologenous leukemia / Helen E. White, Matthew Salmon, Francesco Albano, Christina Søs Auður Andersen, Stefan Balabanov, Gu… , 25 May 2022. - 9 S.
  In: Leukemia, ISSN 1476-5551. 36(2022), 7, Seite 1834-1842
  DOI: 10.1038/s41375-022-01607-z
• Pfeifer, Heike: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 / H. Pfeifer, G. Cazzaniga, V.H.J. van der Velden, J.M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S.… , 11 March 2019. - 13 S.
  In: Leukemia, ISSN 1476-5551. 33(2019), 8, Seite 1910-1922
  DOI: 10.1038/s41375-019-0413-0
• Saußele, Susanne: Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI) : a prespecified interim analysis of a prospective, multicentre, non-randomised, trial / Susanne Saussele, Johan Richter, Joelle Guilhot, Franz X Gruber, Henrik Hjorth-Hansen, Antonio Almei… , May 4, 2018. - 11 S.
  In: The lancet, ISSN 1474-5488. 19(2018), 6, Seite 747-757
  DOI: 10.1016/S1470-2045(18)30192-X
• Saußele, Susanne: Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML Study IV / Susanne Saussele, Rüdiger Hehlmann, Alice Fabarius, Sabine Jeromin, Ulrike Proetel, Sebastien Rinald… , 26 February 2018. - 7 S.
  In: Leukemia, ISSN 1476-5551. 32(2018), 5, Seite 1222-1228
  DOI: 10.1038/s41375-018-0055-7
• Cortés, Jorge Eduardo: Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia : final 5-year results of the phase 2 PACE trial / Jorge E. Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp D. le Coutre, Ronald Paquette, Charles… , [26 July 2018]. - 12 S. : Diagramme
  In: Blood, ISSN 1528-0020. 132(2018), 4, Seite 393-404
  DOI: 10.1182/blood-2016-09-739086
• Proschmann, S. Rick: Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy / Rick Proschmann, Christoph Baldow, Tino Rothe, Meinolf Suttorp, Christian Thiede, Josephine T. Tauer… , 2017. - 4 S.
  In: Haematologica, ISSN 1592-8721. 102(2017), 2, Seite e39-e42
  DOI: 10.3324/haematol.2016.154138
• Vigneri, Paolo: High BCR-ABL/GUS-IS levels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib / Paolo Vigneri, Fabio Stagno, Stefania Stella, Alessandra Cupri, Stefano Forte, Michele Massimino, Ag… , September 19,2017. - 10 S.
  In: Clinical cancer research, ISSN 1557-3265. 23(2017), 23, Seite 7189-7198
  DOI: 10.1158/1078-0432.CCR-17-0962
• Schütz, Christian: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML / C. Schütz, S. Inselmann, S. Sausslele, C.T. Dietz, M.C. Müller, E. Eigendorff, C.A. Brendel, S.K. Me… , 27 January 2017. - 8 S.
  In: Leukemia, ISSN 1476-5551. 31(2017), 4, Seite 829-836
  DOI: 10.1038/leu.2017.9
• Barreto Miranda, Manuel: Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment : long-term observation in CML Study IV / M.B. Miranda, M. Lauseker, M.-P. Kraus, U. Proetel, B. Hanfstein, A. Fabarius, G.M. Baerlocher, D. H… , 26 February 2016. - 8 S.
  In: Leukemia, ISSN 1476-5551. 30(2016), 6, Seite 1255-1262
  DOI: 10.1038/leu.2016.20
• Cross, Nicholas C. P.: Development and evaluation of a secondary reference panel for <i>BCR-ABL1</i> quantification on the International Scale / N.C.P. Cross, H.E. White, T. Ernst, L. Welden, C. Dietz, G. Saglio, F.-X. Mahon, C.C. Wong, D. Zheng… , 25 April 2016. - 9 S.
  In: Leukemia, ISSN 1476-5551. 30(2016), 9, Seite 1844-1852
  DOI: 10.1038/leu.2016.90
• Padula, William V.: Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States / William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rudiger Hehlmann, Miche… , 4 March 2016. - 9 S.
  In: Journal of the National Cancer Institute, ISSN 1460-2105. 108(2016,7) Artikel-Nummer djw003, 9 Seiten
  DOI: 10.1093/jnci/djw003
• Boch, Tobias: Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples : results of a prospective multicentre study / T. Boch, B. Spiess, O.A. Cornely, J.J. Vehreschild, P.M. Rath, J. Steinmann, W.J. Heinz, J. Hahn, S.… , 5 July 2016. - 7 S.
  In: Clinical microbiology and infection, ISSN 1469-0691. 22(2016), 10, Seite 862-868
  DOI: 10.1016/j.cmi.2016.06.021
• Prinzhorn, Wiltrud: c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia / Wiltrud Prinzhorn; Michael Stehle; Helga Kleiner; Sabrina Ruppenthal; Martin C. Müller; Wolf-Karsten… . -
  London: BioMed Central, 2016. - 1 Online-Ressource
• Prinzhorn, Wiltrud: c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia / Wiltrud Prinzhorn, Michael Stehle, Helga Kleiner, Sabrina Ruppenthal, Martin C. Müller, Wolf-Karsten… , 2 March 2016
  In: Biomarker Research, ISSN 2050-7771. 4(2016) Artikel-Nummer 5, 9 Seiten
  DOI: 10.1186/s40364-016-0059-2
• Gratwohl, Alois: Long-term outcome of patients with newly diagnosed chronic myeloid leukemia : a randomized comparison of stem cell transplantation with drug treatment / A. Gratwohl, M. Pfirrmann, A. Zander, N. Kröger, D. Beelen, J. Novotny, C. Nerl, C. Scheid, K. Spiek… , 2016. - 8 S.
  In: Leukemia, ISSN 1476-5551. 30(2016), 3, Seite 562-569
  DOI: 10.1038/leu.2015.281
• Deininger, Michael Werner Nikolaus: Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients / Michael W. Deininger, J. Graeme Hodgson, Neil P. Shah, Jorge E. Cortes, Dong-Wook Kim, Franck E. Nic… , 2016. - 10 S.
  In: Blood, ISSN 1528-0020. 127(2016), 6, Seite 703-712
  DOI: 10.1182/blood-2015-08-660977
• Hochhaus, Andreas: Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase : results from the European ENEST1st study / A. Hochhaus, G. Rosti, N.C.P. Cross, J.L. Steegmann, P. le Coutre, G. Ossenkoppele, L. Petrov, T. Ma… , 2016. - 8 S.
  In: Leukemia, ISSN 1476-5551. 30(2016), 1, Seite 57-64
  DOI: 10.1038/leu.2015.270
• Cross, Nicholas C. P.: Response to Ho-Wan Ip and Chi-Chiu / N.C.P. Cross, M.C. Müller and A. Hochhaus, 22 May 2015. - 1 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 7, Seite 1619
  DOI: 10.1038/leu.2015.97
• Burchert, Andreas: Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia / A. Burchert, S. Saussele, E. Eigendorff, M.C. Müller, K. Sohlbach, S. Inselmann, C. Schütz, S.K. Met… , 25 February 2015. - 5 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 6, Seite 1331-1335
  DOI: 10.1038/leu.2015.45
• Hochhaus, Andreas: Nilotinib in patients with systemic mastocytosis : analysis of the phase 2, open-label, single-arm nilotinib registration study / Andreas Hochhaus, Michele Baccarani, Francis J. Giles, Philipp D. le Coutre, Martin C. Müller, Andre… , 23 May 2015. - 14 S.
  In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 141(2015), 11, Seite 2047-2060
  DOI: 10.1007/s00432-015-1988-0
• Wenn, K.: Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib : letters to the editor / K. Wenn, L. Tomala, S. Wilop, L. Vankann, C. Hasenbank, O. Frank, A. Hochhaus, F.J. Giles, T. Lange,… , 15 September 2015. - 3 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 12, Seite 2402-2404
  DOI: 10.1038/leu.2015.245
• Cross, Nicholas C. P.: Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia / N.C.P. Cross, H.E. White, D. Colomer, H. Ehrencrona, L. Foroni, E. Gottardi, T. Lange, T. Lion, K. M… , 05 February 2015. - 5 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 5, Seite 999-1003
  DOI: 10.1038/leu.2015.29
• Hanfstein, Benjamin: Response-related predictors of survival in CML / Benjamin Hanfstein, Martin C. Müller, Andreas Hochhaus, April 2015. - 13 S.
  In: Annals of hematology, ISSN 1432-0584. 94(2015), Supplement 2, Seite S227-S239
  DOI: 10.1007/s00277-015-2327-x
• Cross, Nicholas C. P.: Molecular monitoring of chronic myeloid leukemia : principles and interlaboratory standardization / Nicholas C.P. Cross, Andreas Hochhaus, Martin C. Müller, April 2015. - 7 S.
  In: Annals of hematology, ISSN 1432-0584. 94(2015), Supplement 2, Seite S219-S225
  DOI: 10.1007/s00277-015-2315-1
• Saußele, Susanne: Impact of comorbidities on overall survival in patients with chronic myeloid leukemia : results of the randomized CML Study IV / Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann, Michael Lauseker, Ulrike Proetel, Lida Kalman… , 2 July 2015. - 8 S.
  In: Blood, ISSN 1528-0020. 126(2015), 1, Seite 42-49
  DOI: 10.1182/blood-2015-01-617993
• Fabarius, Alice: Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML / Alice Fabarius, Lida Kalmanti, Christian T. Dietz, Michael Lauseker, Sébastien Rinaldetti, Claudia H… , December 2015. - 10 S.
  In: Annals of hematology, ISSN 1432-0584. 94(2015), 12, Seite 2015-2024
  DOI: 10.1007/s00277-015-2494-9
• Boch, Tobias: Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples / T. Boch, M. Reinwald, P. Postina, O.A. Cornely, J.J. Vehreschild, C.P. Heußel, W.J. Heinz, M. Hoenig… , December 2015. - 11 S.
  In: Mycoses, ISSN 1439-0507. 58(2015), 12, Seite 735-745
  DOI: 10.1111/myc.12424
• Kalmanti, Lida: Safety and efficacy of imatinib in CML over a period of 10 years : data from the randomized CML-study IV / L. Kalmanti, S. Saussele, M. Lauseker, M.C. Müller, C.T. Dietz, L. Heinrich, B. Hanfstein, U. Proete… , May 2015. - 10 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 5, Seite 1123-1132
  DOI: 10.1038/leu.2015.36
• Prinzhorn, Wiltrud: Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay / Wiltrud Haaß; Helga Kleiner; Martin C. Müller; Wolf-Karsten Hofmann; Alice Fabarius; Wolfgang Seifar… , 2015. - 19 S.
  In: PLOS ONE, ISSN 1932-6203. 10(2015,8) Artikel-Nr. e0133769, 19 S.
  DOI: 10.1371/journal.pone.0133769
• Prinzhorn, Wiltrud: Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy / Wiltrud Haaß; Helga Kleiner; Christel Weiß; Claudia Haferlach; Brigitte Schlegelberger; Martin C. Mü… , 2015. - 18 S.
  In: PLOS ONE, ISSN 1932-6203. 10(2015,6) Artikel-Nr. e0129648, 18 S.
  DOI: 10.1371/journal.pone.0129648
• Lauseker, Michael: A multi-state model approach for prediction in chronic myeloid leukaemia / Michael Lauseker, Joerg Hasford, Verena S. Hoffmann, Martin C. Müller, Rüdiger Hehlmann, Markus Pfir… , 3 December 2014. - 9 S.
  In: Annals of hematology, ISSN 1432-0584. 94(2015), 6, Seite 919-927
  DOI: 10.1007/s00277-014-2246-2
• White, Helen: A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR / H. White, L. Deprez, P. Corbisier, V. Hall, F. Lin, S. Mazoua, S. Trapmann, A. Aggerholm, H. Andriko… , 2015. - 8 S.
  In: Leukemia, ISSN 1476-5551. 29(2015), 2, Seite 369-376
  DOI: 10.1038/leu.2014.217
• Soverini, Simona: Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia / Simona Soverini, Susan Branford, Franck E. Nicolini, Moshe Talpaz, Michael W.N. Deininger, Giovanni … , January 2014. - 11 S.
  In: Leukemia research, ISSN 1873-5835. 38(2014), 1, Seite 10-20
  DOI: 10.1016/j.leukres.2013.09.011
• Erben, Philipp: The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis / Philipp Erben, Juliana Schwaab, Georgia Metzgeroth, Hans-Peter Horny, Mohamad Jawhar, Karl Sotlar, A… , 2014. - 8 S.
  In: Annals of hematology, ISSN 1432-0584. 93(2014), 1, Seite 81-88
  DOI: 10.1007/s00277-013-1964-1
• Philipp, Martin Bernd: Expression of transketolase‑like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML) / M. Philipp, J. Schwaab, C.T. Dietz, B. Hanfstein, L. Kalmanti, U. Munjal, M. Mossner, Nowak W. Seifa… , March 2014. - 7 S.
  In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 3, Seite 411-417
  DOI: 10.1007/s00432-013-1579-x
• Proetel, Ulrike: Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients : a subanalysis of the randomized CML-Study IV / Ulrike Proetel, Nadine Pletsch, Michael Lauseker, Martin C. Müller, Benjamin Hanfstein, Stefan W. Kr… , 2014. - 10 S.
  In: Annals of hematology, ISSN 1432-0584. 93(2014), 7, Seite 1167-1176
  DOI: 10.1007/s00277-014-2041-0
• Agrawal, Mridul: MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure / Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha,… , 2014. - 8 S.
  In: Leukemia, ISSN 1476-5551. 28(2014), 7, Seite 1478-1485
  DOI: 10.1038/leu.2014.6
• Saußele, Susanne: Allogeneic hematopoietic stem cell transplantation (HSCT) in the Imatinib-era : update on the survival outcome following allogeneic HSCT after Imatinib failure : results of the german CML study IV / Susanne Saussele, Michael Lauseker, Martin C. Müller, Alois Gratwohl, Dietrich Beelen, Donald W. Bun… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014), 21
• Saußele, Susanne: Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML-study IV / Susanne Saussele, Rüdiger Hehlmann, Christian Dietz, Susanne Schnittger, Alice Charlotte Fabarius, L… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 69967, 1 S.
• Müller, Martin Christian: Achieving early landmark response is predictive of outcomes in heavily pretreated patients with chronic phase chronic myeloid leukemia (CP-CML) treated with Ponatinib / Martin C. Mueller, Michele Baccarani, Michael W. Deininger, Francois Guilhot, Andreas Hochhaus, Timo… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 72705, 1 S.
• Mahon, François-Xavier: Interim analysis of a Pan European stop tyrosine kinase inhibitor trial in chronic myeloid leukemia : the EURO-SKI study / Francois-Xavier Mahon, Johan Richter, Joelle Guilhot, Martin C. Muller, Christian Dietz, Kimmo Porkk… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 74060, 1 S.
• Ilander, Mette Matilda: Early disease relapse after tyrosine kinase inhibitor treatment discontinuation in CML is related both to low number and impaired function of NK-Cells / Mette Matilda Ilander, Ulla Olsson-Strömberg, Hanna Lähteenmäki, Kasanen Tiina, Perttu Koskenvesa, S… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 66989, 1 S.
• Hanfstein, Benjamin: Comparing the prognostic significance of early predictors of survival in chronic myeloid leukemia (CML) treated with imatinib : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Michael Lauseker, Rüdiger Hehlmann, Susanne Saussele, Philipp Erben, Christian D… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 70540, 1 S.
• Hanfstein, Benjamin: A two-fold rise of BCR-ABL transcript levels advises BCR-ABL mutation analysis in imatinib-treated chronic myeloid leukemia (CML) : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Niklas Westhoff, Rüdiger Hehlmann, Susanne Saussele, Michael Lauseker, Thomas Er… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 3138, 1 S.
• Hanfstein, Benjamin: Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib / Hanfstein, Benjamin ... Hehlmann, Ruediger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fab… , 2014. - 7 S.
  In: Haematologica, ISSN 1592-8721. 99d(2014), 9, Seite 1441-1447
  DOI: 10.3324/haematol.2013.096537
• Dietz, Christian: Prognostic value of multi-drug resistance 1 gene ( MDR1) expression in newly diagnosed patients with chronic myeloid leukemia on nilotinib treatment : a subanalysis of the ENEST1st study / Christian Dietz, Michael Lauseker, Benjamin Hanfstein, Philippe Rousselot, Thoralf Lange, Jacqueline… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 3144, 1 S.
• Cortés, Jorge Eduardo: Long-Term follow-up of ponatinib efficacy and safety in the phase 2 PACE trial / Jorge E. Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp Le Coutre, Ronald Paquette, Charles Ch… , 2014. - 1 S.
  In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 73035, 1 S.
• Hehlmann, Rüdiger: Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib : results from the randomized CML-study IV / Hehlmann, Rüdiger; Müller, Martin C.; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schre… , 2014. - 9 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 5, Seite 415-423
  DOI: 10.1200/JCO.2013.49.9020
• Hanfstein, Benjamin: Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib / Hanfstein, B.; Shlyakhto, V. ... Hehlmann, R.; Saussele, S.; Dietz, C.; Erben, P.; Fabarius, A.; Pro… , 2014. - 5 S.
  In: Leukemia, ISSN 1476-5551. 28(2014), 10, Seite 1988-1992
  DOI: 10.1038/leu.2014.153
• Lauseker, Michael: Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase / Lauseker, Michael; Hanfstein, Benjamin ... Fabarius, Alice ... Saussele, Susanne; Dietz, Christian T… , 2014. - 5 S.
  In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 11, Seite 1965-1969
  DOI: 10.1007/s00432-014-1746-8
• Davies, Andrea: Dual glutathione-s-transferase-theta 1 and -mu 1 gene deletions determine imatinib failure in chronic myeloid leukemia / Davies, A. ... Mueller, M. C. ..., 2014. - 10 S.
  In: Clinical pharmacology & therapeutics, ISSN 1532-6535. 96(2014), 6, Seite 694-703
  DOI: 10.1038/clpt.2014.176
• Nicolini, Franck E.: The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis / Franck E. Nicolini, Amr R. Ibrahim, Simona Soverini, Giovanni Martinelli, Martin C. Müller, Andreas … , October 2013
  In: Haematologica, the hematology journal, ISSN 1592-8721. 98(2013), 10, Seite 1510-1516
  DOI: 10.3324/haematol.2012.080234
• Kalmanti, Lida: Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators : results from the randomized CML study IV / Lida Kalmanti, Susanne Saussele, Michael Lauseker, Ulrike Proetel, Martin C. Müller, Benjamin Hanfst… , 2014. - 10 S.
  In: Annals of hematology, ISSN 1432-0584. 93(2014), 1, Seite 71-80
  DOI: 10.1007/s00277-013-1937-4
• Horn, Matthias: Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia / Horn, Matthias ... Mueller, Martin C.; Hehlmann, Ruediger ..., 2013. - 7 S.
  In: Blood, ISSN 1528-0020. 121(2013), 2, Seite 378-384
  DOI: 10.1182/blood-2012-07-441956
• Giannoudis, Athina: The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia / Giannoudis, Athina ... Mueller, Martin C. ..., 2013. - 10 S.
  In: Blood, ISSN 1528-0020. 121(2013), 4, Seite 628-637
  DOI: 10.1182/blood-2012-01-405035
• Stein, Andrew M.: Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia / Stein, Andrew M. ... Mueller, Martin C. ..., 2013. - 10 S.
  In: BMC cancer, ISSN 1471-2407. 13(2013) Artikel-Nummer 173, 10 Seiten
  DOI: 10.1186/1471-2407-13-173
• Lange, Thoralf: The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia / Lange, Thoralf ... Mueller, Martin C. ..., 2013. - 4 S.
  In: Haematologica, the hematology journal, ISSN 1592-8721. 98(2013), 5, Seite 714-717
  DOI: 10.3324/haematol.2012.068890
• Bolton-Gillespie, Elisabeth: Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells / Bolton-Gillespie, Elisabeth ... Mueller, Martin C. ..., 2013. - 9 S.
  In: Blood, ISSN 1528-0020. 121(2013), 20, Seite 4175-4183
  DOI: 10.1182/blood-2012-11-466938
• White, Helen: Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale / White, Helen E. ... Mueller, Martin C. ..., 2013. - 11 S.
  In: Clinical chemistry, ISSN 1530-8561. 59(2013), 6, Seite 938-948
  DOI: 10.1373/clinchem.2012.196477
• Baccarani, Michele: European LeukemiaNet recommendations for the management of chronic myeloid leukemia : 2013 / Baccarani, Michele ... Mueller, Martin C. ... Saussele, Susanne ... Hehlmann, Ruediger, 2013. - 13 S.
  In: Blood, ISSN 1528-0020. 122(2013), 6, Seite 872-884
  DOI: 10.1182/blood-2013-05-501569
• Nicolini, Franck E.: The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis / Franck E. Nicolini, Amr R. Ibrahim, Simona Soverini, Giovanni Martinelli, Martin C. Müller, Andreas … , 2013. - 7 S.
  In: Haematologica, the hematology journal, ISSN 0390-6078. 98(2013), 10, Seite 1510-1516
• Cortés, Jorge Eduardo: A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias / Cortes, J. E. ... Mueller, M. C. ..., 2013. - 14 S.
  In: The New England journal of medicine, ISSN 1533-4406. 369(2013), 19, Seite 1783-1796
  DOI: 10.1056/NEJMoa1306494
• La Rosée, Paul: Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib / La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ..., 2013. - 6 S.
  In: Annals of hematology, ISSN 0939-5555. 92(2013), 10, Seite 1345-1350
• How, Gee Fung: Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient / Gee Fung How, Martin C. Müller, Lay Cheng Lim, January 2012. - 2 S.
  In: Leukemia research, ISSN 1873-5835. 36(2012), 1, Seite e20-e21
  DOI: 10.1016/j.leukres.2011.08.011
• Cross, Nicholas C. P.: Standardized definitions of molecular response in chronic myeloid leukemia / N.C.P. Cross, H.E. White, M.C. Müller, G. Saglio, & A. Hochhaus, 16 April 2012. - 4 S.
  In: Leukemia, ISSN 1476-5551. 26(2012), 10, Seite 2172-2175
  DOI: 10.1038/leu.2012.104
• Nowak, Daniel: SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3 / Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, Maximilian Mossner, Florian Nolte, Verena Nowa… , 9 April 2012. - 12 S.
  In: Genes, chromosomes & cancer, ISSN 1098-2264. 51(2012), 8, Seite 756-767
  DOI: 10.1002/gcc.21961
• Hanfstein, Benjamin: Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) / B Hanfstein, MCMü̈ller, R Hehlmann, P Erben, M Lauseker, A Fabarius, S Schnittger, C Haferlach, G Gö… , 24 April 2012. - 7 S.
  In: Leukemia, ISSN 1476-5551. 26(2012), 9, Seite 2096-2102
  DOI: 10.1038/leu.2012.85
• Hochhaus, Andreas: Befundinterpretation der molekularen Diagnostik in der Verlaufskontrolle der chronischen myeloischen Leukämie : Empfehlungen einer deutschen Expertengruppe / Andreas Hochhaus, Martin C. Müller, Thoralf Lange, Christian Thiede and Torsten Haferlach, 12.11.2012. - 7 S.
  In: Laboratoriumsmedizin, ISSN 1439-0477. 36(2012), 6, Seite 405-411
  DOI: 10.1515/labmed-2012-0022
• Branford, Susan: Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib / Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop… , 2012. - 7 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 30(2012), 35, Seite 4323-4329
  DOI: 10.1200/JCO.2011.40.5217
• Baccarani, Michele: Chronic myeloid leukemia : ESMO clinical practice guidelines for diagnosis, treatment and follow-up / M. Baccarani, S. Pileri, J.-L. Steegmann, M. Muller, S. Soverini, M. Dreyling, 2012. - 6 S.
  In: Annals of oncology, ISSN 1569-8041. 23(2012), suppl_7, Seite vii72-vii77
  DOI: 10.1093/annonc/mds228
• Branford, Susan: Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib / Branford, Susan ... Mueller, Martin C., 2012. - 7 S.
  In: Journal of clinical oncology, ISSN 0732-183X. 30(2012), 35, Seite 4323-4329
• Hochhaus, Andreas: Befundinterpretation der molekularen Diagnostik in der Verlaufskontrolle der chronischen myeloischen Leukämie : Empfehlungen einer deutschen Expertengruppe / Hochhaus, Andreas; Mueller, Martin C. ..., 2012. - 7 S.
  In: Laboratoriumsmedizin, ISSN 0342-3026. 36(2012), 6, Seite 405-411
• Baccarani, Michele: Chronic myeloid leukemia : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up / Baccarani, M. ... Muller, M. ..., 2012. - 6$nSupplement
  In: Annals of oncology, ISSN 0923-7534. 23(2012), 7, Seite 72-77
• Hochhaus, Andreas: Impact of BCR-ABL mutations on patients with chronic myeloid leukemia / Andreas Hochhaus, Paul La Rosée, Martin C. Müller, Thomas Ernst, Nicholas C.P. Cross, 15 Jan 2011. - 11 S. : Diagramme
  In: Cell cycle, ISSN 1551-4005. 10(2011), 2, Seite 250-260
  DOI: 10.4161/cc.10.2.14537
• Hehlmann, Rüdiger: Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia / Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine P… , March 21, 2011. - 9 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 29(2011), 12, Seite 1634-1642
  DOI: 10.1200/JCO.2010.32.0598
• Hehlmann, Rüdiger: Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia / Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine P… , 2011. - 9 S.
  In: Journal of clinical oncology, ISSN 0732-183X. 29(2011), 12 vom: 20. Apr., Seite 1634-1642
• Fabarius, Alice: Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML : long-term observation of 1151 patients from the randomized CML Study IV / Alice Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Müller, Benjamin Hanfstein, Claudia Hafer… , December 22, 2011. - 9 S.
  In: Blood, ISSN 1528-0020. 118(2011), 26, Seite 6760-6768
  DOI: 10.1182/blood-2011-08-373902
• Härtel, Nicolai: Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells : a potential mechanism of altered leukemogenicity / Nicolai Härtel, Thomas Klag, Benjamin Hanfstein, Martin C. Mueller, Thomas Schenk, Philipp Erben, An… , 2012. - 10 S.
  In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 138(2012), 2, Seite 203-212
  DOI: 10.1007/s00432-011-1086-x
• White, Helen: Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA / Helen E. White, Paul Matejtschuk, Peter Rigsby, Jean Gabert, Feng Lin, Y. Lynn Wang, Susan Branford,… , [November 25, 2010]. - 7 S. : Diagramme
  In: Blood, ISSN 1528-0020. 116(2010), 22 vom: Nov., Seite e111-e117
  DOI: 10.1182/blood-2010-06-291641
• Saußele, Susanne: Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era : evaluation of its impact within a subgroup of the randomized German CML Study IV / Susanne Saussele, Michael Lauseker, Alois Gratwohl, Dietrich W. Beelen, Donald Bunjes, Rainer Schwer… , March 11, 2010. - 6 S.
  In: Blood, ISSN 1528-0020. 115(2010), 10, Seite 1880-1885
  DOI: 10.1182/blood-2009-08-237115
• Hughes, Timothy P.: Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia : an analysis from the International Randomized Study of Interferon and STI571 (IRIS) / Timothy P. Hughes, Andreas Hochhaus, Susan Branford, Martin C. Müller, Jaspal S. Kaeda, Letizia Foro… , November 11, 2010. - 8 S. : Diagramme
  In: Blood, ISSN 1528-0020. 116(2010), 19 vom: Nov., Seite 3758-3765
  DOI: 10.1182/blood-2010-03-273979
• Erben, Philipp: Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis / Philipp Erben, Darko Gosenca, Martin C. Müller, Jelena Reinhard, Joannah Score, Francesco del Valle,… , 2010-05-01. - 7 S.
  In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 5 vom: Mai, Seite 738-744
  DOI: 10.3324/haematol.2009.016345
• Müller, Martin Christian: Standardisierung der molekulargenetischen Diagnostik und Verlaufskontrolle bei Patienten mit chronischer myeloischer Leukämie / vorgelegt von Martin Christian Müller, 2008. - 137 Bl. : Ill., graph. Darst., Kt.
• Frühauf, Stefan: Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis / Stefan Fruehauf, Julian Topaly, Eike C. Buss, Thomas Fischer, Oliver G. Ottmann, Bertold Emmerich, M… , 05 March 2007. - 7 S. : Diagramme
  In: Cancer, ISSN 1097-0142. 109(2007), 8, Seite 1543-1549
  DOI: 10.1002/cncr.22535
• Krämer, Alwin: JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia / Alwin Krämer, Andreas Reiter, Jens Kruth, Philipp Erben, Andreas Hochhaus, Martin Müller, Nicholas C… , [July 2007]. - 3 S. : Diagramme
  In: The lancet, ISSN 1474-5488. 8(2007), 7, Seite 658-660
  DOI: 10.1016/S1470-2045(07)70206-1
• Frank, Oliver: Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients / O. Frank, B. Brors, A. Fabarius, L. Li, M. Haak, S. Merk, U. Schwindel, C. Zheng, M.C. Müller, N. Gr… , 25 May 2006. - 8 S.
  In: Leukemia, ISSN 1476-5551. 20(2006), 8, Seite 1400-1407
  DOI: 10.1038/sj.leu.2404270
• Walz, Christoph: Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene / Christoph Walz, Claire Curtis, Susanne Schnittger, Beate Schultheis, Georgia Metzgeroth, Claudia Sch… , 14 July 2006. - 7 S.
  In: Genes, chromosomes & cancer, ISSN 1098-2264. 45(2006), 10, Seite 950-956
  DOI: 10.1002/gcc.20359
• Lahaye, Tanja: Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center / Tanja Lahaye, Birte Riehm, Ute Berger, Peter Paschka, Martin C. Müller, Sebastian Kreil, Kirsten Mer… , 03 March 2005. - 11 S.
  In: Cancer, ISSN 1097-0142. 103(2005), 8, Seite 1659-1669
  DOI: 10.1002/cncr.20922
• Müller, Martin Christian: Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia / Martin C. Müller, Tanja Hördt, Peter Paschka, Kirsten Merx, Paul La Rosée, Rüdiger Hehlmann, Andreas… , May 2004. - 4 S.
  In: Acta haematologica, ISSN 1421-9662. 112(2004), 1-2, Seite 30-33
  DOI: 10.1159/000077557
• Paschka, Peter: Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission / P. Paschka, M.C. Müller, K. Merx, S. Kreil, C. Schoch, T. Lahaye, A. Weisser, A. Petzold, H. König, … , 10 September 2003. - 8 S.
  In: Leukemia, ISSN 1476-5551. 17(2003), 9, Seite 1687-1694
  DOI: 10.1038/sj.leu.2403033
• Burchert, Andreas: Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia / Andreas Burchert, Stefan Wölfl, Manuel Schmidt, Cornelia Brendel, Barbara Denecke, Dali Cai, Larissa… , January 1, 2003. - 6 S.
  In: Blood, ISSN 1528-0020. 101(2003), 1, Seite 259-264
  DOI: 10.1182/blood-2002-02-0659
• Müller, Martin Christian: Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C / M. C. Müller, N. Gattermann, T. Lahaye, M. W. N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. … , 02 October 2003. - 9 S.
  In: Leukemia, ISSN 1476-5551. 17(2003), 12, Seite 2392-2400
  DOI: 10.1038/sj.leu.2403157
• Hochhaus, Andreas: Aktuelle Therapiekonzepte bei chronischer myeloischer Leukämie : Die Studie IV der Deutschen CML-Studiengruppe / A. Hochhaus, U. Berger, A. Reiter, G. Engelich, T. Lahaye, S. Kreil, K. Merx, M.C. Müller, R. Hehlma… , 2002. - 17 S.
  In: Der Internist, ISSN 1432-1289. 43(2002), 10, Seite 1228-1244
  DOI: 10.1007/s00108-002-0706-6
• Hochhaus, Andreas: Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy / A. Hochhaus, S. Kreil, A.S. Corbin, P. La Rosée, M.C. Müller, T. Lahaye, B. Hanfstein, C. Schoch, N.… , 28 October 2002. - 7 S.
  In: Leukemia, ISSN 1476-5551. 16(2002), 11, Seite 2190-2196
  DOI: 10.1038/sj.leu.2402741
• Hochhaus, Andreas: Diagnostik und Therapie der chronischen myeloischen Leukämie / A. Hochhaus, M.C. Müller, R. Hehlmann, 2002. - 15 S.
  In: Der Onkologe, ISSN 1433-0415. 8(2002), 7, Seite 693-707
  DOI: 10.1007/s00761-002-0332-x
• Merx, Kirsten: Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α / K. Merx, M.C. Müller, S. Kreil, T. Lahaye, P. Paschka, C. Schoch, A. Weisser, C. Kuhn, U. Berger, H.… , 30 August 2002. - 5 S.
  In: Leukemia, ISSN 1476-5551. 16(2002), 9, Seite 1579-1583
  DOI: 10.1038/sj.leu.2402680
• Müller, Martin Christian: Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization / M.C. Müller, K. Merx, A. Weiβer, S. Kreil, T. Lahaye, R. Hehlmann, A. Hochhaus, 26 November 2002. - 5 S.
  In: Leukemia, ISSN 1476-5551. 16(2002), 12, Seite 2395-2399
  DOI: 10.1038/sj.leu.2402734
• Hochhaus, Andreas: Monitoring of residual disease in patients with chronic myelogenous leukemia using specific fluorescent hybridization probes for real-time quantitative RT-PCR / Andreas Hochhaus, Michael Emig, Andreas Weisser, Susanne Saussele, Martin Müller, Paul La Rosée, Ch… , 2001. - 15 S.
  In: Rapid Cycle Real-Time PCR. (2001), Seite 171-185
  DOI: 10.1007/978-3-642-59524-0_20
• Hochhaus, Andreas: Detection and quantification of residual disease in chronic myelogenous leukemia / A. Hochhaus, A. Weisser, P. La Rosée, M. Emig, M.C. Müller, S. Saußele, A. Reiter, C. Kuhn, U. Berge… , 06 June 2000. - 8 S.
  In: Leukemia, ISSN 1476-5551. 14(2000), 6, Seite 998-1005
  DOI: 10.1038/sj.leu.2401811
• Saußele, Susanne: Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes / S Saußele, A Weißer, MC Müller, M Emig, P La Rosée, P Paschka, C Kuhn, A Willer R. Hehlmann and A Ho… , 02 November 2000. - 5 S.
  In: Leukemia, ISSN 1476-5551. 14(2000), 11, Seite 2006-2010
  DOI: 10.1038/sj.leu.2401929
• Müller, Martin Christian: Die Bedeutung von antilymphozytären Antikörpern in der Immunpathogenese der HIV-Erkrankung bei Erwachsenen sowie bei Kindern HIV-positiver Mütter / vorgelegt von Martin Christian Müller, 1999. - 96 Bl. : graph. Darst.

IDs

GND:

121360296

Links

Müller, Martin Christian in ...

• Deutsche Nationalbibliothek (DNB)
• Virtual International Authority File (VIAF)

Export publication list

• RIS (Endnote)
• BibTeX
• RDF
• MODS
• P°NK (ExIni)

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).